deflahit

Introduction to Deflahit

Deflahit is a medication primarily used to treat a condition known as Duchenne muscular dystrophy (DMD). This is a muscle-weakening disease that affects children aged 5 and older. Deflahit helps manage the symptoms by reducing inflammation and suppressing the immune system.

Composition of Deflahit

The active ingredient in Deflahit is Deflazacort. It works by converting into an active form that binds to the glucocorticoid receptor in cells, which helps reduce the production of inflammatory substances and suppresses the immune response.

Uses of Deflahit

• Treatment of Duchenne muscular dystrophy (DMD) in children aged 5 and older
• Reduction of inflammation
• Suppression of the immune system

Side Effects of Deflahit

Common Side Effects:

• Weight gain
• Increased appetite
• Round face (Cushingoid appearance)
• Upper respiratory infections (common cold)
• Frequent urination
• Nose and throat inflammation
• Excessive hair growth
• Irritability

Serious Side Effects:

• Allergic reactions
• Symptoms of steroid withdrawal syndrome, such as loss of appetite, nausea, vomiting, tiredness, and headache

Precautions of Deflahit

Deflahit should not be taken by individuals who are allergic to it or any of its ingredients. It should be used with caution during pregnancy and breastfeeding. Stopping Deflahit suddenly can lead to steroid withdrawal syndrome, so it is important to follow the doctor's instructions carefully.

How to Take Deflahit

• Take Deflahit once daily by mouth.
• The recommended dose is about 0.9 mg for each kilogram of body weight.
• It can be taken with or without food.
• Avoid taking it with grapefruit juice.

Conclusion of Deflahit

Deflahit is an effective medication for managing Duchenne muscular dystrophy in children. By reducing inflammation and suppressing the immune system, it helps alleviate symptoms associated with the condition. However, it is important to be aware of potential side effects and follow medical advice closely to ensure safe and effective use.